Off-label use of intravitreal triamcinolone acetonide for diabetic macular edema in a pregnant patient
Ahad Fazelat, Kameran LashkariSchepens Eye Research Institute, Harvard Medical School, Boston, MA, USAAbstract: We present a case of diabetic macular edema in a pregnant patient treated with a single intravitreal injection of triamcinolone acetonomide. Initial presentation and serial examinations af...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2011
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/9da011186cc943b79d5e7da1b9de087a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| Résumé: | Ahad Fazelat, Kameran LashkariSchepens Eye Research Institute, Harvard Medical School, Boston, MA, USAAbstract: We present a case of diabetic macular edema in a pregnant patient treated with a single intravitreal injection of triamcinolone acetonomide. Initial presentation and serial examinations after treatment included visual acuity, slit-lamp examination, indirect ophthalmoscopy, and optical coherence tomography. Resolution of visual acuity and macular edema were present six weeks after injection and persisted throughout the duration of the pregnancy without further intervention. No adverse outcomes for either mother or fetus were noted. To our knowledge, this is the first report of intravitreal triamcinolone administration in this patient population to be published in the medical literature.Keywords: triamcinolone, macular edema, diabetes, pregnancy |
|---|